[
    [
        {
            "time": "",
            "original_text": "太平洋证券维持欧普康视买入评级：欧普康视深度报告——好风凭借力、天高任飞翔",
            "features": {
                "keywords": [
                    "欧普康视",
                    "买入评级",
                    "深度报告",
                    "好风凭借力",
                    "天高任飞翔"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "眼科"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "太平洋证券维持欧普康视买入评级：欧普康视深度报告——好风凭借力、天高任飞翔",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "太平洋证券：欧普康视（300595.SZ）国内角膜塑形镜领军企业，首予“买入”评级",
            "features": {
                "keywords": [
                    "欧普康视",
                    "角膜塑形镜",
                    "领军企业",
                    "买入评级"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "眼科"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "太平洋证券：欧普康视（300595.SZ）国内角膜塑形镜领军企业，首予“买入”评级",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "行业竞争加剧核心产品增长放缓 欧普康视实际控制人前脚减持后脚推定增 减持股份",
            "features": {
                "keywords": [
                    "行业竞争",
                    "核心产品",
                    "增长放缓",
                    "欧普康视",
                    "实际控制人",
                    "减持",
                    "定增"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "眼科"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "行业竞争加剧核心产品增长放缓 欧普康视实际控制人前脚减持后脚推定增 减持股份",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]